NCT01413022 2016-09-19
FOLFIRINOX Plus PF-04136309 in Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma
Washington University School of Medicine
Phase 1 Completed
Washington University School of Medicine
City of Hope Medical Center